BREAST NEOPLASM
Clinical trials for BREAST NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BREAST NEOPLASM trials appear
Sign up with your email to follow new studies for BREAST NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation technique aims to spare heart in breast cancer patients
Disease control OngoingThis study tests a precise type of radiation called proton therapy for women with stage II or III breast cancer. The goal is to see if it can treat the cancer effectively while reducing damage to the heart and lowering the risk of future heart problems or new cancers. About 220 p…
Matched conditions: BREAST NEOPLASM
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 23, 2026 20:48 UTC
-
Hope for advanced breast cancer: new combo targets resistant tumors
Disease control OngoingThis study tests whether adding abemaciclib to fulvestrant can slow or stop the growth of a common type of advanced breast cancer (HR+, HER2-) that has worsened after initial treatment. About 368 participants will receive either the drug combo or a placebo plus fulvestrant. The g…
Matched conditions: BREAST NEOPLASM
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
New program aims to help breast cancer survivors get back to work
Knowledge-focused OngoingThis study tests a new program to help breast cancer patients return to work after treatment. It includes 16 working-age women who have work difficulties. The program offers meetings and support from a team of specialists. The goal is to see if this approach is practical and help…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC
-
New imaging tracer could reveal how fast breast cancer grows
Knowledge-focused OngoingThis study tests a new imaging agent called [18F]ISO-1 to see if it can measure sigma-2 receptor activity in breast cancer tumors using a PET/CT scan. About 30 adults with known or suspected breast cancer will receive the tracer and undergo imaging. The goal is to see if the scan…
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:04 UTC
-
New website helps cancer patients decide on fertility options
Knowledge-focused OngoingThis study tests a decision aid website designed to help women with cancer make informed choices about preserving their fertility before treatment. About 130 women with newly diagnosed breast, colorectal, or reproductive system cancers, or lymphoma/myeloma, will use the website o…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:08 UTC
-
Can a simple reminder save lives? singapore tests new outreach to boost breast cancer screening
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find the best way to remind Singaporean women aged 50-69 who are overdue for a mammogram to schedule one. About 12,750 women will be randomly assigned to receive different reminders, such as letters, phone calls, or app notifications. The goal is to see which m…
Matched conditions: BREAST NEOPLASM
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:04 UTC
-
New study tracks nerve pain from breast cancer drug
Knowledge-focused OngoingThis study follows 36 people with HER2-positive breast cancer who are receiving the drug T-DM1. Researchers want to learn how often and how severely the drug causes nerve damage (peripheral neuropathy), such as numbness, tingling, or pain. Participants will report their symptoms …
Matched conditions: BREAST NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:03 UTC
-
New imaging technique could reveal early signs of drug success in metastatic breast cancer
Knowledge-focused OngoingThis study tests whether a special PET scan (FLT PET/CT) can show changes in tumor activity in people with metastatic breast cancer that has spread beyond the liver and bones. About 20 participants will receive the drug ribociclib followed by ribociclib plus paclitaxel, and have …
Matched conditions: BREAST NEOPLASM
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC